Literature DB >> 28437204

Drainage Percutaneous Endoscopic Gastrostomy for Malignant Bowel Obstruction in Gastrointestinal Cancers: Prognosis and Implications for Timing of Palliative Intervention.

Kerry-Ann Pinard1, Tabitha N Goring2, Barbara C Egan2, Douglas J Koo2.   

Abstract

BACKGROUND: Malignant bowel obstruction (MBO) is a frequent complication in patients with advanced solid tumors. Palliative relief may be achieved by the use of a drainage percutaneous endoscopic gastrostomy (dPEG) tube, although optimal timing of placement remains unknown.
OBJECTIVES: To determine median survival after diagnosis of MBO and dPEG placement, factors associated with worse survival in MBO, factors associated with receipt of dPEG, and association of timing of dPEG placement on survival.
METHODS: This observational retrospective cohort study examined 439 patients with MBO on a gastrointestinal medical oncology inpatient service. Patients were characterized by age, gender, race, primary cancer type, length of stay, readmission, complications (aspiration pneumonia or bowel perforation), and receipt of dPEG. Select factors were analyzed to examine overall survival (OS) and dPEG placement.
RESULTS: Median survival from diagnosis of first MBO was 2.5 months. Median survival after dPEG placement was 37 days. In univariate analysis, dPEG placement, complications, longer length of stay, and readmissions were significantly associated with worse OS. Receipt of dPEG was significantly associated with younger age, longer length of stay at first admission, and shorter interval to readmission. In patients who received dPEG, longer interval from MBO diagnosis to dPEG placement did not affect OS.
CONCLUSION: We found that prognosis following diagnosis of MBO in patients with gastrointestinal malignancies remains poor. Our data suggest that timing of dPEG placement in MBO does not affect OS and, therefore, earlier intervention with this procedure may allow earlier and prolonged palliative relief.

Entities:  

Keywords:  drainage percutaneous endoscopic gastrostomy; gastrointestinal malignancy; malignant bowel obstruction

Mesh:

Year:  2017        PMID: 28437204     DOI: 10.1089/jpm.2016.0465

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  4 in total

1.  The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations.

Authors: 
Journal:  Ann Surg Oncol       Date:  2020-04-13       Impact factor: 5.344

2.  [Percutaneous endoscopic gastrostomy in geriatrics : Indications, technique and complications].

Authors:  Rainer Wirth
Journal:  Z Gerontol Geriatr       Date:  2018-01-18       Impact factor: 1.281

3.  Illness Understanding, Prognostic Awareness, and End-of-Life Care in Patients With GI Cancer and Malignant Bowel Obstruction With Drainage Percutaneous Endoscopic Gastrostomy.

Authors:  Jessica I Goldberg; Debra A Goldman; Sarah McCaskey; Douglas J Koo; Andrew S Epstein
Journal:  JCO Oncol Pract       Date:  2020-08-06

4.  MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.

Authors:  Ainhoa Madariaga; Jenny Lau; Arunangshu Ghoshal; Tomasz Dzierżanowski; Philip Larkin; Jacek Sobocki; Andrew Dickman; Kate Furness; Rouhi Fazelzad; Gregory B Crawford; Stephanie Lheureux
Journal:  Support Care Cancer       Date:  2022-03-10       Impact factor: 3.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.